Literature DB >> 8595863

A stable Escherichia coli-mycobacteria shuttle vector 'pSO246' in Mycobacterium bovis BCG.

S Matsumoto1, M Tamaki, H Yukitake, T Matsuo, M Naito, H Teraoka, T Yamada.   

Abstract

The most widely used plasmid vector system in mycobacteria is based on pAL5000 from Mycobacterium fortuitum. The derivatives of the pAL5000-based shuttle vectors between Escherichia coli and mycobacteria, which we have utilized to secrete recombinant antigens, were generated. The stability of the vectors was assessed in Mycobacterium bovis BCG (BCG). The plasmid vector pSO246 was stable in BCG for at least 50 generations.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8595863     DOI： 10.1016/0378-1097(95)00457-2

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN： 0378-1097            Impact factor:   2.742


  13 in total

1.  Control of cell wall assembly by a histone-like protein in Mycobacteria.

Authors:  Tomoya Katsube; Sohkichi Matsumoto; Masaki Takatsuka; Megumi Okuyama; Yuriko Ozeki; Mariko Naito; Yukiko Nishiuchi; Nagatoshi Fujiwara; Mamiko Yoshimura; Takafumi Tsuboi; Motomi Torii; Nobuhide Oshitani; Tetsuo Arakawa; Kazuo Kobayashi
Journal:  J Bacteriol       Date:  2007-09-14       Impact factor: 3.490

2.  Mycobacterial codon optimization enhances antigen expression and virus-specific immune responses in recombinant Mycobacterium bovis bacille Calmette-Guérin expressing human immunodeficiency virus type 1 Gag.

Authors:  Masaru Kanekiyo; Kazuhiro Matsuo; Makiko Hamatake; Takaichi Hamano; Takeaki Ohsu; Sohkichi Matsumoto; Takeshi Yamada; Shudo Yamazaki; Atsuhiko Hasegawa; Naoki Yamamoto; Mitsuo Honda
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Guérin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity.

Authors:  Yasushi Ami; Yasuyuki Izumi; Kazuhiro Matsuo; Kenji Someya; Masaru Kanekiyo; Shigeo Horibata; Naoto Yoshino; Koji Sakai; Katsuaki Shinohara; Sohkichi Matsumoto; Takeshi Yamada; Shudo Yamazaki; Naoki Yamamoto; Mitsuo Honda
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.

Authors:  Kenji Someya; Dayaraj Cecilia; Yasushi Ami; Tadashi Nakasone; Kazuhiro Matsuo; Sherri Burda; Hiroshi Yamamoto; Naoto Yoshino; Masahiko Kaizu; Shuji Ando; Kenji Okuda; Susan Zolla-Pazner; Shudo Yamazaki; Naoki Yamamoto; Mitsuo Honda
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  Protection by a recombinant Mycobacterium bovis Bacillus Calmette-Guerin vaccine expressing Shiga toxin 2 B subunit against Shiga toxin-producing Escherichia coli in mice.

Authors:  Jun Fujii; Mariko Naito; Takashi Yutsudo; Sohkichi Matsumoto; Daniel P Heatherly; Takeshi Yamada; Hideyuki Kobayashi; Shin-Ichi Yoshida; Tom Obrig
Journal:  Clin Vaccine Immunol       Date:  2012-10-03

6.  Development of a new generation of vectors for gene expression, gene replacement, and protein-protein interaction studies in mycobacteria.

Authors:  Amit Parikh; Devanand Kumar; Yogesh Chawla; Krishna Kurthkoti; Shazia Khan; Umesh Varshney; Vinay K Nandicoori
Journal:  Appl Environ Microbiol       Date:  2013-01-11       Impact factor: 4.792

7.  Primary Role of Suppressor of Cytokine Signaling 1 in Mycobacterium bovis BCG Infection.

Authors:  Shogo Soma; Satoru Kawai; Hiroyasu Inada; Kenta Watanabe; Satoru Mizuno; Seiichi Kato; Kazuhiro Matsuo; Yasuhiro Yasutomi
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

8.  Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies.

Authors:  S Matsumoto; H Yukitake; H Kanbara; T Yamada
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

9.  C-terminal intrinsically disordered region-dependent organization of the mycobacterial genome by a histone-like protein.

Authors:  Anna Savitskaya; Akihito Nishiyama; Takehiro Yamaguchi; Yoshitaka Tateishi; Yuriko Ozeki; Masaaki Nameta; Tomohiro Kon; Shaban A Kaboso; Naoya Ohara; Olga V Peryanova; Sohkichi Matsumoto
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

10.  A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Guéren.

Authors:  Yuriko Ozeki; Masayuki Igarashi; Matsumi Doe; Aki Tamaru; Naoko Kinoshita; Yoshitoshi Ogura; Tomotada Iwamoto; Ryuichi Sawa; Maya Umekita; Shymaa Enany; Yukiko Nishiuchi; Mayuko Osada-Oka; Tetsuya Hayashi; Mamiko Niki; Yoshitaka Tateishi; Masaki Hatano; Sohkichi Matsumoto
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.